Category Archives: Publications


Research (R-x) *=refereed
1. *Cooper JW. Serotonin and growth antagonists. New Engl J Med 1973; 289:870 (Letter).

2. *Cooper JW, Ansel HC, Cadwallader DE. Liquid and solid solution interactions of primary certified colorants with pharmaceutical gelatins. J Pharm Sci 1973;62:1156 1164.

3. *Cooper JW, Fish KH, Loomis M et al., A seven nursing home study of the frequency of potential drug drug interactions. J Am Pharm Assoc 1975; NS23:24 27.

4. *Cooper JW, Frisk PA, Walchle RC. Continuous clinical pharmacy care-a method to reduce drug related problems in the small community. J Clin Pharmacol 1975; 15: 55.

5. *Cooper JW, Rhodes CT, Birmingham BK. Pharmacokinetics of salicylic acid. Arch Derm 1976; 112:1610 (Letter).

6. *Lewis KP, Cooper JW, McKercher PL. Pharmacist effect on digoxin usage and toxicity. Amer J Hosp Pharm 1976;33:1272 1276. NOTE: Dr. Lewis was first recipient of the ASHP Student Research Award in 1978 for this work.

7. *Frisk PA, Cooper JW, Campbell NA. Community hospital pharmacist detection of drug related problems upon admission to small community hospitals. Am J Hosp Pharm 1977;34:738 742. Note: This work received the ASHP Award for Achievement in the Professional Practice of Hospital Pharmacy in 1978.

8. *Schwartz PA, Rhodes CT, Cooper JW. Solubility and ionization characteristics of phenytoin. J Pharm Sci 1977;66:994 997.

9. *Cooper JW, Bagwell CG . The contribution of the consultant pharmacist to rational drug usage in the long term care facility. J Am Geriatr Soc 1978;26:513 520.

10. *Cooper JW, Pesnell LS. Thioridazine associated immune hemolytic anemia in an elderly female. Sou Med J 1978;71:1441 1442.

11. *Cooper JW, Walchle RC, McKercher PL. Physician, pharmacist and nurse conducted drug histories. Contemp Pharm Pract 1980;3:75 78.

12. *Cooper JW, McCall CY. Tetracycline esophagitis report of three cases. Pharm Practice. 1979;14:52.

13. *Cooper JW, McCall CY. Tolmetin anaphylactoid reaction. JAMA 1980;243:1263.

14. *Cooper JW. Consultant contributions to rational drug therapy in the long term care facility. Contemp Writings on Long Term Care Pharmacy 1980;2:161 168.

15. *Wade WE, Whaley JA, Cooper JW, Brown RH . Pharmacist involvement in Georgia public health department preliminary report of two pilot studies. Ga Pharm J 1981;3:20 22.

16. *Wilcher DE, Cooper JW. Consultant pharmacist effect on analgesic and antiinflammatory usage in geriatric long term care facility. J Am Geriatr Soc 1981;29:429 432. NOTE: Ms. Wilcher was Sigma Xi Student Research Awardee for this work in 1982.

17. *Tsai AE, Cooper JW, McCall CY. Consultant pharmacist effect on hematopoietic and vitamin therapy in a geriatric long term care facility. Hosp Form 1982;17:225 235.

18. * Lawler RS, Cooper JW, Kotzan JA. Consultant pharmacist input in the treatment of urinary tract infections in a geriatric long term care facility. Hosp Pharm 1980;15:562 572.

19. *Cooper JW, Francisco GE. Consultant clinical pharmacist: effect on psychotropic drug usage in long term care facility geriatric patients. Hosp Form 1981;16:407 419.

20. *Williamson DH, Cooper JW, Kotzan JA. Consultant pharmacist impact on antihypertensive therapy in a geriatric long term care facility. Hosp Form 1984;19:123 128.

21. *Cooper JW. Baked chicken liver and blood pressure increases in geriatric nursing home patients. Am J Clin Nutr 1979;32:1980.

22. * Cooper JW et al., Pharmacy and the Elderly: An Assessment of the Needs of the Elderly and Recommendations for Increasing Geriatric Aspects of Pharmacy Curricula, DHEW Pub. No.(HRA) 80 37 (September, 1979).

23. *Cooper JW, Griffin DL, Francisco GE, et al. Home health care: drug-related problems detected by consultant pharmacist participation. Hosp Form 1985;20:643 650.

24. * Wiederholt J, Kotzan JA, Cooper JW. A tachistoscopic examination of auxiliary prescription labels. Drug Intell Clin Pharm 1983; 17:216 221.

25. *Spruill WJ, Cooper JW, Taylor WJR. Pharmacist coordinated pneumonia and influenza vaccination program. Am J Hosp Pharm 1982; 39:1904 1906.

26. * Spruill WJ, Cooper JW. Enteric coated aspirin efficacy in patients previously treated with non steroidal antiinflammatory agents. Sou Med J 1983; 76:276.

27. *Cooper JW. Drug related problems in geriatric LTCF patients. J Geriatr Drug Ther 1986; 1(1):47 68.

28. * Cooper JW. Effect of initiation, termination and reinitiation of consultant pharmacist services in a geriatric LTCF. Med Care 1985;23:84 86.

29. *Cooper JW, Morgan SM, McCall CY, et al. Dexamethasone prevention of cisplatinum induced nausea and emesis. Curr Ther Res 1985; 38:43 49.

30. * Cooper JW, Cobb HH, Shepherd MD. Drug discards in two Georgia long-term care facilities. Ga Pharm J 1985; 7:11 15.

31. * Cooper JW, Stegeman JF. Sulfisoxazole induced hypoprothrombinemia in an elderly female. J Med Assoc Ga 1981; 70:875 877.

32. * Pink LA, Cooper JW, Francis WR. Digoxin related communications in a long term care facility. Nurs Homes 1985; 34(1):25 31.

33. * Durrence CE, Cooper JW. Gastrointestinal side effects associated with liquid and solid dosage forms of potassium chloride. Curr Ther Res 1984;36:550 556.

34. *Cooper JW. Efficacy and cost effectiveness of a new diuretic combination antihypertensive in a geriatrics long term care facility. Curr Ther Res 1986; 39:160 165.

35. * Wade WE, Cobb HH, Cooper JW. Drug-related problems in a geriatric ambulatory population. J Geriatr Drug Ther 1986; 1(2):101 110.

36. * Durrence CE, May JR, DiPiro JT, Cooper JW. Potential drug interactions in surgical patients. Am J Hosp Pharm 1985; 42:1553 1556.

37. Cooper JW. Trans dermal nitroglycerin efficacy in ambulatory and nursing home geriatric patients. MCP CE Bulletin 1986; 6:25 32.

38. Cooper JW. Drug related problems in nursing home patients. Nurs Homes 1986;35(6): 13 19.

39. Cooper JW. Communications on drug related problems within nursing homes. Nurs Homes 1987; 36(1):11 14.

40. Cooper JW. Drug related problems in nursing homes: Medication Errors.Nurs Homes1987; 36(2):13 16.

41. Cooper JW. Drug related problems in nursing home patients: contraindications to drug usage. Nurs Homes 1987;36(3):5 7.

42. Cooper JW. Adverse drug reactions and interactions in a nursing home. Nurs Homes 1987; 36(4):7 11.

43. Cooper JW. Nutritional problems in nursing home patients. Nurs Homes 1987; 36(5):5 8.

44. Cooper JW . Nursing home drug and nutritional therapy cost savings by the consultant pharmacist. Nurs Homes 1987; 36(6):6 8.

45. Cooper JW. Reduction of irrational drug duplication in geriatric nursing homes. Nurs Homes 1988; 37(1):5 9.

46. Cooper JW. Lack of efficacy of nursing home medications. Nurs Homes 1988;37:(2)6 10.

47. Cooper JW. Underecognition and undertreatment of geriatric nursing home patients. Nurs Homes 1988;37(3):6,9. and *Ga J Hosp Pharm 1989;2(2):18-20.

48. Cooper JW. Lab tests under and overutilization in geriatric nursing home patients. Nurs Homes 1988;37(4):5 8.

49. Cooper JW . Inappropriate drug scheduling. Nurs Homes 1988; 37(5):13 15.

50. * Cooper JW, Cobb HH. Patient nutritional correlates and changes in a geriatric nursing home. Nutr Supp Serv 1988; 8(8):5 7.

51. *Wade WE, Cooper JW. Iatrogenic hyperkalemia in a elderly female. J Geriatr Drug Ther 1986; 1(1):75 79.

52. * Cooper JW, Wade WE, Mallet L. Anemia detection and treatment in a four geriatric long term care facility population. J Pharmacoepidem 1990; 1(1):61 70.

53. *Cooper JW. Nursing home admission orders and the consultant pharmacist. Cons Pharm 1987; 2:152 156.

54. * Cooper JW, Doyal LE. Cost justification of the clinical pharmacist in a community mental health center. Med Interface 1989; 2(11):44 48.

55. * Cooper JW. Drug related problems in geriatric day care patients. Cons Pharm 1988;3(2):193.

56. * Cooper JW. Reduced eye infections in geriatric patients by consultant pharmacist recommendation of continual use of artificial tears. Cons Pharm 1988;3(3):83.

57. * Cooper JW. Drug related problems (DRPs) in geriatric swing bed patients.Cons Pharm 1988;3 (3):83.

58. * Cooper JW. Cost savings from discontinuance of urinary sugar and acetone tests. Cons Pharm 1988;3(3):83.

59. * Morton MR, Spruill WJ, Cooper JW. Pharmacist impact on pneumococcal vaccination rates in LTCFs. Am J Hosp Pharm 1988; 45:73.

60. * Cooper JW. Chronic constipation associations and laxative efficacy in a geriatric nursing home population. J Pharmacoepidem 1991;1(3/4):29 40.

61. * Mallet L, Cooper JW. Catapres TTS medication error. Sou Med J 1988; 81:1597 1598.

62. * Cooper JW, Mallet L. Chlorpropamide half life and urine pH. Am J Med 1988; 85:756 757.

63. * Mallet L, Cooper JW, Thomas J. Captopril pemphigoid reaction. Drug Intell Clin Pharm.1989; 23:63.

64. * Fazio A, Lisi DM, Cooper JW. Acetazolamide Acidosis. J Geriatr Drug Ther 1989;3(3):87 96.

65. * Mallet L, Coulter J, Cooper JW. Cholesterol levels in elderly patients living in a nursing home .Cons Pharm 1989;4:371 373.

66. * Morton MR, Cooper JW. Erythromycin induced digoxin toxicity. DICP Ann Pharmacother 1989; 23:688 9.

67. Cooper JW. Psychoactive drug use and misuse in a 200 bed nursing home population. Nurs Homes 1989;38(1 2):5 7.

68. * Cooper JW, Gordon JE, Parish RC. Diabetes mellitus prevalence and treatment outcomes in a geriatric nursing home population. J Geriatr Drug Ther. 1990; 5(1):73 82.

69. * Cooper JW. Renal function assessment in nursing home patients. A prospective 6 month study in 282 patients. J Geriatr Drug Ther 1991; 5(3):59 72.

70. *Cooper JW. Drug assessment in nursing home patients with renal impairment.J Geriatr Drug Ther 1991; 5(1):73 88.and J Pharmacoepidem. 1992;2(4):3-12.

71. * Mallet L, Cooper JW. Prolongation of prothrombin time with the use of piroxicam and warfarin. Can J Hosp Pharm 1991;44(2):93 4.

72. Cooper JW. Managing depression and depressive symptoms:a five-year study. Nurs Homes 1993; 42(2):37-39.

73. Cooper JW. ACEI Drug Interactions (case reports). Nurs Home Pract 1994;2(5):28-30.

74. * Cooper JW. Falls and fractures in nursing home patients receiving psychotropic drugs.Internat J Geriatr Psych 1994;9:975-80.

75. * Cooper JW. Pharmacotherapy Recommendations from Monthly Drug Regimen Reviews in a Geriatric Nursing Facility: A One-Year Study. Pharmacotherapy 1994; 13:687

76. * Cooper JW. Consultant pharmacist contribution to diabetes mellitus treatment outcomes in two patient outcomes in two nursing faciltites. Cons Pharm 1995;10(1):13-18.

77. * Cooper JW. Adverse drug reactions and interactions in a geriatric nursing home population over 4 years. J Am Geriatr Soc 1996; 44:194-197.

78. * Cooper JW. Falls in nursing home patients receiving classical antihistamines while stabilized on psychoactive medications, J Pharmacoepidem 1996; 5(1):45-50.

79. * Cooper JW. Health Care Costs and Outcomes from Consultant Pharmacist Recommendations in A Geriatric Nursing Facility: A One-year Study. J Geriatr Drug Ther 1997: 11(4):51-73.; also published as Cost-benefit analysis of consultant pharmacist recommendations from monthly drug regimen reviews in a geriatric nursing facility; a one-year study in J Pharmacoepidem 1997: 6(1): 23-36.

80. * Cooper JW. Geriatric drug therapy interventions. J Geriatr Drug Ther 1997; 11(4):3-26.

81. * Cooper JW. Geriatric drug therapy intervention failure and associated costs. J Geriatri Drug Ther 1997;11(4):65-70.

82. * Wade WE, Cooper JW. Bowel obstruction associated with fiber administration within an entire nursing facility population, J Geriatr Drug Ther 1997; 12 (1):94-94.

83. * Cooper JW, Wade WE. Repeated unnecessary NSAID-associated hospitalizations: a case report. J Geriatr Drug Ther 1997; 12 (1): 95-98.

84. * Wade WE, Cooper JW. Severe tardive dyskinesia and weight loss associated with metoclpropamide administration with haloperidol: a case report. J Geriatr Drug Ther 1997; 12 (1): 99-104.

85. * Cooper JW, Wade WE. Possible lower bowel perforation associated with ibuprofen administration: a case report. J Geriatr Drug Ther 1997; 12 (1): 105-108.

86. * Cooper JW. Consultant pharmacist effect on NSAID costs and gastropathy over a 5-year period. Consult Pharm 1997; 12:792-796.

87. * Cooper JW. Consultant pharmacist assessment and reduction of fall risk in nursing facilities. Consult Pharm 1997; 12: 1294-1304.

88. * Cooper JW. Consultant pharmacist assessment of fall injury incidence and costs within a nursing facility. Consult Pharm 1997; 12: 1305-1309.

89. * Cooper JW . Reducing falls among patients in nursing homes. JAMA 1997;278: 1742.

90. * Cooper JW. Consultant pharmacist drug therapy recommendations from monthly drug regimen reviews in a geriatric nursing facility: a two-year study and cost analysis. J Nutri Health and Aging 1997; 1(3): 181-184.

91. * McRae A, Cooper JW. Use of nonaggressive short-term nutritional supplementation in a skilled nursing facility. Consult Pharm 1998; 13:174-181.

92. * Beach JW, Cooper JW, Francisco GE, Langford A. An infectious disease course for an entry-level doctor of pharmacy program. Am J Pharm Ed 1998; 62(2): 296-301.

93. * Cooper JW. Fatal asymptomatic hypoglycemia in an elderly insulin-using diabetic patient, Diabetes Care 1998; 21(12):9-10.

94. * Cooper JW. Oral agent treatment of type 2 diabetes mellitus in older adults. Ann Long Term Care-Nursing Home Medicine 1998; 6: 414-422.

95. * Cooper JW. Adverse drug reaction-related hospitalizations of nursing facility patients: a 4-year study. Sou Med J 1999; 92:485-490.

96. * Cooper JW. Psychoactive drugs may have a role in pressure sore origin. Br Med J 2000; 321:452.

97. Cooper JW, Cobb HH, Burfield AH. A one year study of psychotropic load reduction and buspirone conversion possible effects on behavioral disturbances and global deterioration in a rural nursing home population, Cons Pharm 2001; 16(4):358-363.

98. Cooper JW, Horner MR. Psychotropic load and falls in nursing facility residents, in review. (nominated for ASHP Student Research Award for 2000)

99. Cooper JW. Drugs may have reduced effect of falls intervention. Br Med J 2001; 322:675.

100. Cooper JW. Reducing psychotropic drugs reduces falls in elderly people. Br Med J 2001; 323:402.

101. Fick DM, Cooper JW, Wade WE, Waller J, McLean R, Beers MH. Updating the Beer’s criteria for Potentially Inappropropriate Medication Use in Older Adults. Archives of Internal Medicine, 2003;163:2716-2724.

102. Cooper JW, Burfield AH. Anticholinergics to Avoid with Cholinesterase Inhibitors. Ann Long Term Care 2003; 4(11): 50-51.

103. Cooper JW, Burfield AH. Response to Anticholinergics to Avoid- Quarternary vs. Tertiary Ammonium Antimuscarinics, ibid, May, 2003.

104. Cooper JW. Pseudoephedrine adverse drug effects, Drug Topics 2004; 23;56.

105. Cooper JW., Wade WE. Pharmacists interventions in geriatric nursing facility-NSAID Therapy . Cons Pharm 2005; 20(6): 492-7.

106. Perri M, Menon AM, Desspande AD, Shinde SB, Jiang R, Cooper JW et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005; 39; 405-11.

107. Cooper JW, Burfield AH. Management of the cognitively impaired residents: a practical guide for long-term care. ElderCare 2005; 5(1):3-5.

108. Cooper JW, McCall CY, Marshburn RP, Burfield AH . A senior care clerkship for pharmacy students. Consult Pharm 2006;21:482-92.

109. Cooper JW, Burfield AH . Transitional care of elderly residents with anemia. ElderCare 2005; 6(2):1-5.

110. Cooper JW, Freeman MH, Cook CL, Burfield AH. Psychotropic and Psychoactive Drug Load Assessment and Falls in Nursing Facility Residents.Consult Pharm 2007:22:483-9.

111. Cooper JW, Freeman MH, Cook CL, Burfield AH. Psychotropic and Psychoactive Drugs and Hospitalization Rates in Nursing Facility Residents. Pharmacy Practice 2007;5(3):140-4.

112. Cooper JW, Wade WE, Cook CL, Burfield AH. Consultant Pharmacist Drug Therapy Recommendations Acceptance and Rejection from Monthly Drug Regimen Reviews in A Geriatric Nursing Facility: Fourth Year Results and Cost Analysis. Hosp Pharm 2007;42:729-36.